- UK plans to introduce two new clinical trials on COVID-19 patients.
- Patients will be given blood cancer and pancreatic disease drugs.
- Drug – Ruxolitinib, used to treat various blood cancer patients.
- Drug – Camostat, used to treat inflammation of the pancreas.
In a new development by the UK, two drugs previously used in treating ....
Tags : UNITED KINGDOM, CLINICAL TIRALS, RUXOLITINIB, CAMOSTAT, COVID-19,